Glioma and glioblastoma are types of brain tumors that arise from the glial cells, which are responsible for supporting and nourishing the neurons in the brain. While these tumors share some common features, they also have important differences in terms of their diagnosis, treatment options, and prognosis. National Brain Tumor Society states that it is estimated that more than 10,000 individuals in the United States will succumb to glioblastoma every year.
Platforms like Medditour connect the patients seeking treatment for glioma and glioblastoma with the global hospitals and facilitators for cost-effective treatments.
In this article, let’s explore about the differences between glioma and glioblastoma, their diagnosis and treatment options, and how medical tourism in Singapore, Malaysia, and India could help in its cure.
Glioma vs. Glioblastoma
Glioma is a broad term that refers to a group of tumors that arise from the glial cells in the brain or spinal cord. These tumors can be classified into different types based on their cellular characteristics, location, and growth pattern. Some of the common types of glioma include astrocytoma, oligodendroglioma, and ependymoma. The symptoms of glioma include headaches, seizures, changes in vision, speech problems, and memory loss.
Glioblastoma, also known as glioblastoma multiforme, is the most aggressive and malignant form of glioma. It is characterized by the presence of abnormal and rapidly dividing cells that invade the surrounding brain tissue, making it difficult to remove the entire tumor through surgery.
Diagnosis and treatment options for glioma and glioblastoma
Diagnosis of glioma and glioblastoma typically involves a combination of imaging tests, such as MRI and CT scans, and a biopsy to confirm the presence of abnormal cells. The biopsy is usually performed through a small hole in the skull, and the tissue sample is examined under a microscope to determine the type and grade of the tumor.
Treatment options for glioma and glioblastoma depend on the type and stage of the tumor. Surgery is often the first step in treating glioma, with the goal of removing as much of the tumor as possible without causing damage to the surrounding brain tissue. Radiation therapy and chemotherapy may also be used to kill any remaining cancer cells and prevent the tumor from recurring.
The Brain Tumor Charity states that the average glioblastoma survival time is 12-18 months – only 25% of patients survive more than one year, and only 5% of patients survive more than five years.
Medical tourism for glioma and glioblastoma
Singapore, Malaysia, and India are three countries that have established themselves as leading destinations for medical tourism, offering a wide range of treatments and services at competitive prices.
For patients with glioma and glioblastoma, medical tourism can offer several benefits. Firstly, patients can access world-class treatment options that may not be available in their home country, such as proton therapy or immunotherapy. Secondly, medical tourism can provide cost savings of up to 50-70% compared to the cost of the same treatment in developed countries. Thirdly, medical tourism can offer a more personalized and patient-centered approach to care, with shorter wait times, private rooms, and access to specialized services.
Medical tourism platforms like Medditour help the patients seeking treatments for glioma and glioblastoma to combine the treatment with vacation.
In conclusion, glioma and glioblastoma are serious and often life-threatening brain tumors that require prompt diagnosis and appropriate treatment. With the right care and support and medical tourism glioma and glioblastoma can improve their chances of survival and enjoy a better quality of life.